M
美加康
医疗新闻

中国先进医疗新闻

面向国际患者的CAR-T、干细胞、医疗旅游和医疗政策最新动态。AI精选并标注来源。

IndustryAugust 25, 2026

Huashan Hospital Upgrades International Services: Multilingual Team and Direct Billing with Insurers Launched

Shanghai Huashan Hospital recently announced the upgrade of its international patient services, establishing a multilingual medical coordination team and launching a direct billing channel with international insurers, covering over 30 major insurance companies. This initiative will significantly streamline the medical process for foreign patients and enhance the cross-border healthcare experience.

Read article
IndustryAugust 25, 2026

Huashan Hospital Launches Green Channel for International Patients, Making Cross-Border Medical Care More Convenient

Shanghai Huashan Hospital has officially launched a green channel for international patients seeking medical care, streamlining appointment scheduling, consultation, payment, and follow-up processes. This initiative is expected to significantly enhance the medical experience for foreign patients and support Shanghai's development as an international medical center. The channel covers key departments such as neurosurgery and dermatology, with an estimated annual service capacity exceeding 10,000 international patients.

Read article
IndustryAugust 25, 2026

Ruijin Hospital Leads International Multicenter Trial, Accelerating Innovative Therapies

Shanghai Ruijin Hospital has recently launched an international multicenter clinical trial focusing on novel targets in tumor immunotherapy, in collaboration with multiple medical institutions across Europe, America, and Asia, aiming to accelerate the global simultaneous availability of innovative therapies. This initiative will enhance the international influence of China's clinical research and provide more treatment options for overseas patients.

Read article
IndustryAugust 25, 2026

Shanghai Ruijin Hospital Upgrades International Patient Services, Multilingual Support and Direct Insurance Billing as Highlights

Shanghai Ruijin Hospital recently announced the upgrade of its international patient services, adding a multilingual medical team and direct insurance billing channels, covering languages including English, Japanese, and Korean, with partnerships with over 20 international insurance companies. This initiative aims to streamline the medical process, enhance the experience for foreign patients, and further consolidate its position as a hub for international healthcare in Shanghai.

Read article
IndustryAugust 25, 2026

Shanghai Ruijin Hospital Completes 100th High-Difficulty Endocrine and Hematologic Surgery

Shanghai Ruijin Hospital recently announced the completion of its 100th high-difficulty combined endocrine and hematologic surgery, ranking among the top in the country in clinical experience. Through a multidisciplinary collaboration model, the hospital has successfully managed complex cases, offering more treatment options for international patients.

Read article
IndustryAugust 25, 2026

Shanghai Ruijin Hospital Conquers High-Difficulty Endocrine and Hematologic Surgery, Filling Regional Gap

A multidisciplinary team at Shanghai Ruijin Hospital recently completed a high-difficulty combined surgery for an endocrine tumor with a hematologic disorder, breaking through multiple technical bottlenecks and filling a regional medical gap. The procedure employed a multidisciplinary collaboration model, integrating intraoperative navigation and cell protection technologies, offering a new solution for complex cases.

Read article
IndustryAugust 25, 2026

Ruijin Hospital's Endocrinology and Hematology Research Gains International Recognition

Shanghai Ruijin Hospital recently released the latest clinical research data in the fields of endocrinology and hematology, with multiple innovative therapies showing significant efficacy and earning recognition from authoritative international journals, marking a new milestone in China's clinical research level in these fields.

Read article
TechnologyAugust 25, 2026

New Trends in Refractive Surgery in China: A Clinical Comparison of SMILE and ICL

China's ophthalmic refractive surgery field is undergoing technological iteration, with SMILE laser and ICL implantation emerging as mainstream choices. Latest clinical data show that both offer distinct advantages in correction range, postoperative visual quality, and complication control, driving the adoption of personalized surgical plans and providing international patients with more precise vision correction options.

Read article
TechnologyAugust 25, 2026

China's Cataract Surgery Technology Upgrade: Phacoemulsification Combined with Multifocal Intraocular Lenses

China's ophthalmology field has introduced multifocal intraocular lenses on the basis of phacoemulsification cataract surgery, significantly improving postoperative visual quality. The latest data show that this technology enables patients to achieve clear distance, intermediate, and near vision simultaneously, with a spectacle independence rate exceeding 90%, offering new options for cataract patients worldwide.

Read article
Showing 9 of 162 articles

Subscribe to Our Newsletter

Get the latest medical insights and healthcare news delivered to your inbox.